General Info
Location: Kullagatan 8
Country: Sweden
Industries: Biotechnology, Pharmaceuticals
Investment Regions: EU
Investment Stages: seed, series-a
Website: http://www.aqilion.com/
vc
EU
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: Aqilion AB’s website shows press releases with investment or funding-related activity in 2025, most recently June 5, 2025 and July 18, 2025 and October 16, 2025 concerning the drug candidate AQ280 and TAK1 program. The latest known activity (October 16, 2025) is less than 3 months prior to the reference date, indicating very recent activity. The startup/drug candidate referenced is AQ280.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
Sarah …
CEO
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Aqilion AB
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI